Implications for IV posaconazole dosing in the era of obesity.
Wasmann RE, Smit C, van Donselaar MH, van Dongen EPA, Wiezer RMJ, Verweij PE, Burger DM, Knibbe CAJ, Brüggemann RJM.
Wasmann RE, et al. Among authors: smit c.
J Antimicrob Chemother. 2020 Apr 1;75(4):1006-1013. doi: 10.1093/jac/dkz546.
J Antimicrob Chemother. 2020.
PMID: 31971567
Free PMC article.
Clinical Trial.